SCHEMBL5074705

SCHEMBL5074705

[O]C1(O)CCC(O)C1(O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7768338 0.71
SCHEMBL11231245 0.67
SCHEMBL27949663 0.67
SCHEMBL7086182 0.65
SCHEMBL5066061 0.61
SCHEMBL25438352 0.61
SCHEMBL8984298 0.61
SCHEMBL3189299 0.59
SCHEMBL6266780 0.59
SCHEMBL28167948 0.59 HSD17B10 (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080071116-A1 Modulators of Lysophosphatidic Acid (Lpa) Signaling and the Use Thereof THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) 2008-03-20 US disclosed
WO-2005082914-A2 MODULATORS OF LYSOPHOSPHATIDIC ACID (LPA) SIGNALING BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2005-09-09 WO disclosed
US-4585762-A ANTITUMOR AGENTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1986-04-29 US disclosed